These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11399767)

  • 21. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
    Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
    Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.
    Kumar KG; Varghese B; Banerjee A; Baker DP; Constantinescu SN; Pellegrini S; Fuchs SY
    J Biol Chem; 2008 Jul; 283(27):18566-72. PubMed ID: 18474601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2.
    Rani MR; Gauzzi C; Pellegrini S; Fish EN; Wei T; Ransohoff RM
    J Biol Chem; 1999 Jan; 274(4):1891-7. PubMed ID: 9890942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation.
    Krishnan K; Yan H; Lim JT; Krolewski JJ
    Oncogene; 1996 Jul; 13(1):125-33. PubMed ID: 8700538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase.
    Rani MR; Leaman DW; Han Y; Leung S; Croze E; Fish EN; Wolfman A; Ransohoff RM
    J Biol Chem; 1999 Nov; 274(45):32507-11. PubMed ID: 10542297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TYK2 activity promotes ligand-induced IFNAR1 proteolysis.
    Marijanovic Z; Ragimbeau J; Kumar KG; Fuchs SY; Pellegrini S
    Biochem J; 2006 Jul; 397(1):31-8. PubMed ID: 16551269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of recognition of interferon-α receptor by tyrosine kinase 2.
    Wallweber HJ; Tam C; Franke Y; Starovasnik MA; Lupardus PJ
    Nat Struct Mol Biol; 2014 May; 21(5):443-8. PubMed ID: 24704786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyk2 is essential for IFN-alpha-induced gene expression in mast cells.
    Mori Y; Hirose K; Suzuki K; Nakajima H; Seto Y; Ikeda K; Shimoda K; Nakayama K; Saito Y; Iwamoto I
    Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():25-9. PubMed ID: 15166480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function.
    Shimoda K; Kato K; Aoki K; Matsuda T; Miyamoto A; Shibamori M; Yamashita M; Numata A; Takase K; Kobayashi S; Shibata S; Asano Y; Gondo H; Sekiguchi K; Nakayama K; Nakayama T; Okamura T; Okamura S; Niho Y; Nakayama K
    Immunity; 2000 Oct; 13(4):561-71. PubMed ID: 11070174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
    Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
    Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombopoietin signal transduction requires functional JAK2, not TYK2.
    Drachman JG; Millett KM; Kaushansky K
    J Biol Chem; 1999 May; 274(19):13480-4. PubMed ID: 10224114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growth.
    Kato K; Kamezaki K; Shimoda K; Numata A; Haro T; Aoki K; Ishikawa F; Takase K; Ariyama H; Matsuda T; Miyamoto T; Nagafuji K; Gondo H; Nakayama K; Harada M
    Br J Haematol; 2003 Nov; 123(3):528-35. PubMed ID: 14617019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
    Walters DK; Jelinek DF
    Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway.
    Yang CH; Murti A; Valentine WJ; Du Z; Pfeffer LM
    J Biol Chem; 2005 Jul; 280(27):25849-53. PubMed ID: 15883164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species-specific regulation of Toll-like receptor 3 genes in men and mice.
    Heinz S; Haehnel V; Karaghiosoff M; Schwarzfischer L; Müller M; Krause SW; Rehli M
    J Biol Chem; 2003 Jun; 278(24):21502-9. PubMed ID: 12672806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction.
    Kusch A; Tkachuk S; Haller H; Dietz R; Gulba DC; Lipp M; Dumler I
    J Biol Chem; 2000 Dec; 275(50):39466-73. PubMed ID: 10995743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.
    Kumar KG; Krolewski JJ; Fuchs SY
    J Biol Chem; 2004 Nov; 279(45):46614-20. PubMed ID: 15337770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta.
    Barbieri G; Velazquez L; Scrobogna M; Fellous M; Pellegrini S
    Eur J Biochem; 1994 Jul; 223(2):427-35. PubMed ID: 8055912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo.
    Painz R; Walter I; Kolbe T; Rigler D; Vogl C; Steinborn R; Rülicke T; Helmreich M; Karaghiosoff M; Müller M
    Immunobiology; 2007; 212(9-10):863-75. PubMed ID: 18086385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.